SG11202003493VA - Composition for treating skin cell damage caused by fine dust, containing green tea-derived lactic acid bacteria - Google Patents

Composition for treating skin cell damage caused by fine dust, containing green tea-derived lactic acid bacteria

Info

Publication number
SG11202003493VA
SG11202003493VA SG11202003493VA SG11202003493VA SG11202003493VA SG 11202003493V A SG11202003493V A SG 11202003493VA SG 11202003493V A SG11202003493V A SG 11202003493VA SG 11202003493V A SG11202003493V A SG 11202003493VA SG 11202003493V A SG11202003493V A SG 11202003493VA
Authority
SG
Singapore
Prior art keywords
composition
lactic acid
acid bacteria
green tea
damage caused
Prior art date
Application number
SG11202003493VA
Inventor
Seung Hyun Shin
Kilsun Myoung
Yongjoo Na
Original Assignee
Amorepacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amorepacific Corp filed Critical Amorepacific Corp
Publication of SG11202003493VA publication Critical patent/SG11202003493VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SG11202003493VA 2017-10-31 2018-08-17 Composition for treating skin cell damage caused by fine dust, containing green tea-derived lactic acid bacteria SG11202003493VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020170143715A KR101993270B1 (en) 2017-10-31 2017-10-31 Composition comprising lactic acid bacteria derived from green tea for caring damages of skin cells by microdust
PCT/KR2018/009465 WO2019088421A1 (en) 2017-10-31 2018-08-17 Composition for treating skin cell damage caused by fine dust, containing green tea-derived lactic acid bacteria

Publications (1)

Publication Number Publication Date
SG11202003493VA true SG11202003493VA (en) 2020-05-28

Family

ID=66333319

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202003493VA SG11202003493VA (en) 2017-10-31 2018-08-17 Composition for treating skin cell damage caused by fine dust, containing green tea-derived lactic acid bacteria

Country Status (4)

Country Link
KR (1) KR101993270B1 (en)
CN (1) CN111315357B (en)
SG (1) SG11202003493VA (en)
WO (1) WO2019088421A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210104953A (en) 2020-02-17 2021-08-26 (주)아모레퍼시픽 Composition for relieving itching or inflammation caused by microdust
KR102574601B1 (en) * 2022-11-04 2023-09-08 엘앤피코스메틱(주) Preparation method of cosmetic composition comprising tea tree extracts and cosmetic composition prepared thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2704704T3 (en) * 2011-05-03 2019-01-14 Dupont Nutrition Biosci Aps PROBIOTIC BACTERIES FOR TOPICAL TREATMENT OF SKIN DISORDERS
KR101998210B1 (en) * 2012-10-31 2019-07-10 (주)아모레퍼시픽 A composition containing tea lactic acid bacteria for exfoliating skin
KR20170032815A (en) * 2015-09-15 2017-03-23 경희대학교 산학협력단 Novel lactic acid bacteria and composition for preventing, improving or treating neurodegenerative diseases or cognitive dysfunction

Also Published As

Publication number Publication date
CN111315357B (en) 2023-05-05
KR20190048613A (en) 2019-05-09
KR101993270B1 (en) 2019-06-26
WO2019088421A1 (en) 2019-05-09
CN111315357A (en) 2020-06-19

Similar Documents

Publication Publication Date Title
EP3269378A4 (en) Composition for preventing or treating inflammatory diseases, comprising lactic acid bacteria-derived extracellular vesicles as active ingredients
HK1251147A1 (en) Composition for preventing hair loss or promoting hair growth comprising extracellular follicle derived from lactic acid bacteria
EP3165227A4 (en) Composition for treating or preventing metabolic disease, containing, as active ingredient, extracellular vesicles derived from akkermansia muciniphila bacteria
IL277028A (en) A composition comprising a 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3h-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine or a derivative thereof for use in the treatment of a cell proliferative disorder
WO2015148863A3 (en) Crispr/cas-related methods and compositions for treating sickle cell disease
SG11201601363YA (en) Process for purifying an acid composition comprising 2-formyl-furan-5-carboxylic acid and 2,5-furandicarboxylic acid
SG11201707087PA (en) Composition for diagnosing skin damage caused by fine dust, and composition comprising galangin as active ingredient
EP2883875A4 (en) N2,n4-bis(4-(piperazine-1-yl)phenyl)pirimidine-2,4-diamine derivative or pharmaceutically acceptable salt thereof, and composition containing same as active ingredient for preventing or treating cancer
ZA201507571B (en) Process for making 2,5-furandicarboxylic acid
KR102429539B9 (en) Composition for cryoprotecting lactic acid bacteria containing citrate
EP3342858A4 (en) Ror1-positive mesenchymal stem cells and method for preparing same, pharmaceutical composition containing ror1-positive mesenchymal stem cells and method for preparing same, and method for preventing or treating diseases by using ror1-positive mesenchymal stem cells
SG11201704321TA (en) Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition comprising same
GEP201706760B (en) Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same
HRP20200104T8 (en) Novel heterocyclic compound, method for preparing the same, and pharmaceutical composition comprising the same
EP2982678A4 (en) Novel phytospingosine-1-phosphate derivative, preparation method therefor, and composition for preventing and treating hair loss or for growing hair comprising same
PT2770979E (en) Improved cross-linking composition delivered by iontophoresis, useful for the treatment of keratoconus
SG11202003493VA (en) Composition for treating skin cell damage caused by fine dust, containing green tea-derived lactic acid bacteria
IL251456A0 (en) Compound having gpr119 agonistic activity, method for preparing the same, and pharmaceutical composition including the same as effective component
EP3037091A4 (en) Composition containing monoacetyldiacylglycerol compound as active ingredient for preventing or treating asthma
SG11201704766UA (en) Antibacterial composition containing adk protein as active ingredient, or composition for preventing or treating septicemia
SG11202003286YA (en) Cool-sensation imparter composition containing 2,2,6-trimethylcyclohexanecarboxylic acid derivative
EP2862573A4 (en) Composition for treating or preventing diseases caused by vascular permeability, containing imatinib or pharmaceutically acceptable salt thereof as active ingredient
GB2559718B (en) Novel crystalline form of tribenuron-methyl, process for preparation and use thereof
IL273738A (en) Method for preparing cell extract component or composition exhibiting cytocidal activity
SG11202002451TA (en) Composition for treating fine dust-caused skin cell damage, comprising prunus mume flower extract